Marksans Pharma Ltd.
SET SMS ALERT
| 5-Day | 264,888 |
| 10-Day | 610,082 |
| 30-Day | 319,864 |
| 5-Day | 264,888 |
| 10-Day | 610,082 |
| 30-Day | 319,864 |
Depth
Market Depth (18 Aug 2018)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 600 | 32.30 | 32.35 | 176 |
| 2945 | 32.20 | 32.45 | 800 |
| 1351 | 32.15 | 32.50 | 3690 |
| 5000 | 32.10 | 32.60 | 1400 |
| 7475 | 32.05 | 32.65 | 2 |
| 31.82 K | Total | 48.91 K | Total |
Buy Qty
31.82 K
Sell QTY
48.91 K
| 5-Day | 2,263,788 |
| 10-Day | 4,393,397 |
| 30-Day | 2,297,130 |
| 5-Day | 2,263,788 |
| 10-Day | 4,393,397 |
| 30-Day | 2,297,130 |
- Quote
- CHARTS
- NEWS
- COMMENTS5 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Marksans Pharma
Sentimeter
100% of moneycontrol users recommend buying Marksans Pharma.
What's your call on Marksans Pharma today?
Read 5 investor views
Top Trading Ideas
17 August 2018
buy ITC Aug Fut |
Entry Price (Rs) 305.20 |
Exit Price (Rs) 314.25 |
Gain (Rs) 9.00 |
buy StridesPharma Aug Fut |
Entry Price (Rs) 427.55 |
Exit Price (Rs) 445.50 |
Gain (Rs) 18.00 |
buy BataIndia Aug Fut |
Entry Price (Rs) 999.00 |
Exit Price (Rs) 1,014.00 |
Gain (Rs) 15.00 |
| Days | BSE | NSE |
| 30 | 28.46 | 28.50 |
| 50 | 28.61 | 28.65 |
| 150 | 33.02 | 33.03 |
| 200 | 35.04 | 35.04 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Marksans Pharma
| Standalone | Jun'18 | Mar'18 | Dec'17 | Sep'17 |
| Net Sales | 93.14 | 86.84 | 80.03 | 75.41 |
| Other Income | 3.22 | 0.08 | 0.00 | 0.00 |
| PBDIT | 17.08 | 10.74 | 11.51 | 6.37 |
| Net Profit | 13.87 | 4.33 | 5.62 | 1.32 |
(In Rs Cr)
| Total Share Capital | 40.93 |
| Net Worth | 428.97 |
| Total Debt | 66.31 |
| Net Block | 87.89 |
| Investments | 236.07 |
| Total Assets | 495.27 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 623.30 | 0.60 | 633.25 | 434.80 | 149,549.91 |
| Cipla | 648.15 | 0.12 | 663.00 | 508.10 | 52,190.13 |
| Piramal Enter | 2706.35 | -0.17 | 3014.90 | 2279.05 | 48,874.66 |
| Lupin | 879.35 | 3.53 | 1090.00 | 723.55 | 39,758.94 |
| Dr Reddys Labs | 2363.35 | 0.66 | 2611.80 | 1888.00 | 39,231.33 |
| More » | |||||
| Jun' 18 | Mar' 18 | Sep' 17 | Jun' 17 | |
| Promoter | 48.25 | 48.25 | 48.25 | 48.25 |
| Public (FII + DII) | 51.75 | 51.75 | 51.75 | 51.75 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| No Mutual Funds Holding the share |
Meghmani Organics Recommended on Aug 27th 2017
Recommended price 73.00 | Peak from reco 129.40 78.11%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Marksans Pharma
Marksans Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,326.18 crore.
The company management includes Mark Saldanha - Chairman & Managing Director, Sandra Saldanha - Whole Time Director, Seetharama R Buddharaju - Independent Director, Ajay S Joshi - Independent Director, Vinay Gopal Nayak - Whole Time Director, Digant Mahesh Parikh - Independent Director.
It is listed on the BSE with a BSE Code of 524404 and the NSE with an NSE Code of MARKSANS.
Its Registered office is at 11th Floor, Grandeur, , Mumbai,Maharashtra - 400053.
Their Registrars are Bigshare Services Pvt. Ltd.
